presentación de powerpoint - aad highlights · • alopecia areata: jak inhibitors, new peptides...

3
Trichology Dr. Sergio Vañó. Hospital Ramon y Cajal, Madrid

Upload: others

Post on 14-Oct-2020

7 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Presentación de PowerPoint - AAD Highlights · • Alopecia areata: JAK inhibitors, new peptides under development (BNZ-1) • Scarring alopecias: low-dose naltrexone for LPP •

TrichologyDr. Sergio Vañó. Hospital Ramon y Cajal, Madrid

Page 2: Presentación de PowerPoint - AAD Highlights · • Alopecia areata: JAK inhibitors, new peptides under development (BNZ-1) • Scarring alopecias: low-dose naltrexone for LPP •

• Session: S023: Hair and scalp dermoscopy• Peripilar sign: Brown depressed area indicating microinflammation in AGA.

Sign of early AGA. • Specific marker of trichotillomania: flame hairs• FFA: absence of vellus hairs• FFA trichoscopic activity index: relationship between peripilar casts and

histological inflammation.

• Therapeutic hotlines (Jerry Shapiro, Wilma Bergfeld, Rod Sinclair)• AGA: oral minoxidil (safe and even better than topical), activation of Wnt

pathway (microneedling, LLLT, topical agonists – SM 04554).• Alopecia areata: JAK inhibitors (new era), preclinical studies of anti-IL 15

(BNZ-1) • Hair transplantation: endoscopic harvesting (not yet available), criticism to

“low-cost” clinics in Turkey

Page 3: Presentación de PowerPoint - AAD Highlights · • Alopecia areata: JAK inhibitors, new peptides under development (BNZ-1) • Scarring alopecias: low-dose naltrexone for LPP •

General conclusions

• Increasing interest in trichology: full rooms• Absence of lectures about frontal fibrosing alopecia• AGA: therapies with newm mechanisms, mainly activation of

Wnt pathway. Microneedling, LLLT. • Alopecia areata: JAK inhibitors, new peptides under

development (BNZ-1)• Scarring alopecias: low-dose naltrexone for LPP• Importance of trichoscopy: essential for dermatologists

interested in trichology• New lines of research: genomics, microbiome, regenerative

medicine.